Nav: Home

Coping with arthritis: What you do isn't associated with how much information you want

December 29, 2016

Chapel Hill, NC - Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Carolina Eshelman School of Pharmacy. Study findings suggest that the attentional coping styles of patients with rheumatoid arthritis (RA) and osteoarthritis (OA) tend not to be associated with self-management behaviors such as how often patients have medication related discussions with their doctors and medication adherence.

The study was published online September 30, 2016 in The Open Rheumatology Journal.

There is no cure for arthritis and patients, often faced with a range of stressors such as adjusting to fluctuations in symptoms (e.g. joint pain) and treatment (e.g. medication changes), engage in coping strategies such as accessing medication-related information. Many studies have assessed attentional coping style in a variety of acute health contexts (e.g. cancer screening) and few studies have explored coping styles among patients with chronic diseases (e.g. asthma and multiple sclerosis), where stress is present but not always acute. Findings tend to be consistent: when confronted with medical stressors, monitors attend to and prefer more information, while blunters tend to avoid and prefer less information.

"When we investigated the relationship between RA and OA patients' attentional coping styles and behaviors related to medication information we were surprised that we did not see results in accordance with the characteristic patterns outlined in the acute and chronic disease coping literature," said Lorie Geryk, postdoctoral fellow in the Division of Pharmaceutical Outcomes and Policy at Eshelman School of Pharmacy and lead author of the study. "In fact, counter to expected coping trends, we found that higher monitoring was associated with less information-receipt for RA patients and among OA patients, higher blunting was associated with more information-receipt."

More research is needed to better understand the long term relationship between coping style and patient medication-related behaviors in order to help clarify why and when health-relevant information is likely to benefit arthritis patients.
-end-
Funding for the study came from the Thurston Arthritis Research Center Postdoctoral Fellowship number 5T32-AR007416; Novartis Pharmaceuticals, and the ACR REF/Abbott Health Professional Graduate Student Research Preceptorship; and the National Center for Research Resources under grant number UL1RR025747.

For more information about the article, please visit https://benthamopen.com/ABSTRACT/TORJ-10-60

Reference: Geryk, L. L.; et al (2016). Medication-related Self-management Behaviors among Arthritis Patients: Does Attentional Coping Style Matter?. Open Rheumatol J., DOI: 10.2174/1874312901610010060

Bentham Science Publishers

Related Rheumatoid Arthritis Articles:

New pieces added to the molecular puzzle of rheumatoid arthritis
researchers have revealed new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
Thermal cameras effective in detecting rheumatoid arthritis
A new study, published today in Scientific Reports, highlights that thermal imaging has the potential to become an important method to assess Rheumatoid Arthritis.
Rheumatoid arthritis -- can its onset be delayed or prevented?
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs.
Disease burden in osteoarthritis is similar to rheumatoid arthritis
Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.
Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.
Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.
How environmental pollutants and genetics work together in rheumatoid arthritis
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.
Rheumatoid arthritis meets precision medicine
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new multi-site study.
Causes of death in rheumatoid arthritis patients
Mortality rates were increased for patients with rheumatoid arthritis relative to the general population across all causes of death in a recent Arthritis Care & Research analysis.
Menopause found to worsen symptoms of rheumatoid arthritis
A recent study published in Rheumatology suggests that women with rheumatoid arthritis suffer a greater decline in physical function following menopause.
More Rheumatoid Arthritis News and Rheumatoid Arthritis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.